The international journal of cardiovascular imaging · 2018
Imaging the myocardial ischemic cascade.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Stillman Arthur E, Oudkerk Matthijs, Bluemke David A, de Boer Menko Jan, Bremerich Jens, Garcia Ernest V, Gutberlet Matthias, van der Harst Pim, Hundley W Gregory, Jerosch-Herold Michael, Kuijpers Dirkjan, Kwong Raymond Y, Nagel Eike, Lerakis Stamatios, Oshinski John, Paul Jean-François, Slart Riemer H J A, Thourani Vinod, Vliegenthart Rozemarijn, Wintersperger Bernd J
Аннотация
Non-invasive imaging plays a growing role in the diagnosis and management of ischemic heart disease from its earliest manifestations of endothelial dysfunction to myocardial infarction along the myocardial ischemic cascade. Experts representing the North American Society for Cardiovascular Imaging and the European Society of Cardiac Radiology have worked together to organize the role of non-invasive imaging along the framework of the ischemic cascade. The current status of non-invasive imaging for ischemic heart disease is reviewed along with the role of imaging for guiding surgical planning. The issue of cost effectiveness is also considered. Preclinical disease is primarily assessed through the coronary artery calcium score and used for risk assessment. Once the patient becomes symptomatic, other imaging tests including echocardiography, CCTA, SPECT, PET and CMR may be useful. CCTA appears to be a cost-effective gatekeeper. Post infarction CMR and PET are the preferred modalities. Imaging is increasingly used for surgical planning of patients who may require coronary artery bypass.